BIT 2.56% 2.0¢ biotron limited

Thoughts, page-16

  1. 7,624 Posts.
    lightbulb Created with Sketch. 968
    Lifetoshort , this drug is not experimental , why did we do clinical 2 trials , it achieved equal results to other drugs that are on market , and with a lot less side effects . Management , just aren't doing their job as marketers , they are scientists . The last results should have been all over the news via a PR company and in every glossy magazine , A milestone achievement in the world of drugs by a small biotech in Aussie land . I believe it will be purchased as a combo drug by somebody , and who knows possibly even the existing players who have on market drugs .

    No Michelle does not own any shares and I too find it offensive that she doesn't , all other management do , One of the directors bought 1,000,000 at five cents a while ago . They all bought in spp too . When questioned about CEO and buying shares , was reported she had a mortgage and four kids to look after .
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
0.001(2.56%)
Mkt cap ! $17.59M
Open High Low Value Volume
2.0¢ 2.0¢ 2.0¢ $919 46.07K

Buyers (Bids)

No. Vol. Price($)
10 1679605 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 191274 4
View Market Depth
Last trade - 10.51am 14/11/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.